Literature DB >> 8593862

Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.

H L Bradlow1, D L Davis, G Lin, D Sepkovic, R Tiwari.   

Abstract

Xenobiotic estrogens are external compounds with estrogenic activity that may thereby affect the risk of breast cancer. This paper describes a mechanism by which xeno-estrogens may affect the development of breast cancer. Estradiol metabolism proceeds by hydroxylation at one of two mutually exclusive sites at C-2 and C-16 alpha. The catechol pathway yields the weakly estrogenic 2-hydroxyestrone (2-OHE1), which inhibits breast cell proliferation. In contrast, the alternative pathway yields the genotoxic 16 alpha-hydroxyestrone (16 alpha-OHE1), which enhances breast cell growth, increases unscheduled DNA synthesis, and oncogene and virus expression, and increases anchorage-independent growth. Using a radiometric assay that measures the relative formation of 16 alpha-OHE1 versus 2-OHE1 from specifically tritiated estradiol in (ER+) MCF-7 cells, we compared the ratio of 16 alpha-OHE1/2-OHE1 observed after treatment with the known rodent carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) with the ratios after treatment with DDT, atrazine, gamma-benzene hexachloride, kepone, coplanar PCBs, endosulfans I and II, linoleic and eicosapentenoic acids, and indole-3-carbinol (I3C). These pesticides significantly increase the ratio of 16 alpha-OHE1/2-OHE1 metabolites to values comparable to or greater than those observed after DMBA. In contrast, the antitumor agent I3C increased 2-OHE1 formation and yielded ratios that are 1/3 of those found in unexposed control cells and 1/10th of those found in DMBA-treated cells. Thus the ratio of 16 alpha-OHE1/2-OHE1 may provide a marker for the risk of breast cancer. Assays of this ratio, which can be measured in spot urines, may prove useful for a variety of in vitro and in vivo studies bearing on breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593862      PMCID: PMC1518879          DOI: 10.1289/ehp.95103s7147

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  27 in total

Review 1.  Effect of diet on the plasma levels, metabolism, and excretion of estrogens.

Authors:  B R Goldin; S L Gorbach
Journal:  Am J Clin Nutr       Date:  1988-09       Impact factor: 7.045

2.  In vitro biotransformation of estradiol by explant cultures of murine mammary tissues.

Authors:  N T Telang; H L Bradlow; H Kurihara; M P Osborne
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

3.  Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation.

Authors:  B Vandewalle; J Lefebvre
Journal:  Mol Cell Endocrinol       Date:  1989-02       Impact factor: 4.102

4.  Abnormal oxidative metabolism of estradiol in women with breast cancer.

Authors:  J Schneider; D Kinne; A Fracchia; V Pierce; K E Anderson; H L Bradlow; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization.

Authors:  G E Swaneck; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice.

Authors:  H L Bradlow; J Michnovicz; N T Telang; M P Osborne
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

7.  Temporal actions of 16 alpha-hydroxyestrone in the rat: comparisons of lordosis dynamics with other estrogen metabolites and between sexes.

Authors:  R H Lustig; C V Mobbs; D W Pfaff; J Fishman
Journal:  J Steroid Biochem       Date:  1989-09       Impact factor: 4.292

8.  Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis.

Authors:  T Niwa; H L Bradlow; J Fishman; G E Swaneck
Journal:  J Steroid Biochem       Date:  1989-08       Impact factor: 4.292

9.  Interaction of histones with estrogens. Covalent adduct formation with 16 alpha-hydroxyestrone.

Authors:  S C Yu; J Fishman
Journal:  Biochemistry       Date:  1985-12-31       Impact factor: 3.162

10.  Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis.

Authors:  B T Zhu; Q D Bui; J Weisz; J G Liehr
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

View more
  33 in total

Review 1.  Environment and health: 6. Endocrine disruption and potential human health implications.

Authors:  G M Solomon; T Schettler
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

Review 2.  Epidemiologic studies of estrogen metabolism and breast cancer.

Authors:  Regina G Ziegler; Barbara J Fuhrman; Steven C Moore; Charles E Matthews
Journal:  Steroids       Date:  2015-02-26       Impact factor: 2.668

Review 3.  Oxidative stress--implications, source and its prevention.

Authors:  Rajbir Kaur; Jasmit Kaur; Jyoti Mahajan; Rakesh Kumar; Saroj Arora
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-30       Impact factor: 4.223

Review 4.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

5.  Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Authors:  Alan A Arslan; Karen L Koenig; Per Lenner; Yelena Afanasyeva; Roy E Shore; Yu Chen; Eva Lundin; Paolo Toniolo; Göran Hallmans; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-27       Impact factor: 4.254

6.  Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women.

Authors:  Kannan Rangiah; Sumit J Shah; Anil Vachani; Eugene Ciccimaro; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2011-05-15       Impact factor: 2.419

7.  Urinary estrogen metabolites during a randomized soy trial.

Authors:  Yukiko Morimoto; Shannon M Conroy; Ian S Pagano; Marissa Isaki; Adrian A Franke; Frank J Nordt; Gertraud Maskarinec
Journal:  Nutr Cancer       Date:  2012-01-31       Impact factor: 2.900

8.  Analysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS.

Authors:  Adrian A Franke; Laurie J Custer; Yukiko Morimoto; Frank J Nordt; Gertraud Maskarinec
Journal:  Anal Bioanal Chem       Date:  2011-06-29       Impact factor: 4.142

9.  Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens.

Authors:  Jessica M Faupel-Badger; Barbara J Fuhrman; Xia Xu; Roni T Falk; Larry K Keefer; Timothy D Veenstra; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

10.  Fat/fiber intakes and sex hormones in healthy premenopausal women in USA.

Authors:  Mylène Aubertin-Leheudre; Sherwood Gorbach; Margo Woods; Johanna T Dwyer; Barry Goldin; Herman Adlercreutz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-08-09       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.